Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride

Clinical and Experimental Metastasis

Volumn 16, Issue 4, 1998, Pages 353-357

  Evans, Douglas M ^a   Sloan Stakleff, Kimberly ^a   Arvan, Michael ^b   Guyton, Daniel P ^a  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Amiloride; Metastatic cancer; Protease inhibitors; Urokinase

Indexed keywords

AMILORIDE; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; FEMALE; LUNG METASTASIS; NONHUMAN; RAT;

AMILORIDE; ANIMALS; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; PLASMINOGEN ACTIVATORS; RATS; RATS, INBRED F344; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031802807     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006517614491     Document Type: Article

References (23)

1. Flamigni C, Bulletti C, Polli V, et al. 1991, Factors regulating interaction between trophoblast and human endometrium. Ann NY Acad Sci, 622, 176-90.
2. Blasi F, 1993, Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15, 105-11.
3. Malone JM, Wangensteen SL, Moore WS and Keown K, 1979, The fibrinolytic system: a key to tumor metastasis? Ann Surg, 190, 342-9.
4. Dano K, Andreasen PA, Grondahl-Hansen J, et al. 1985, Plasminogen activators, tissue degradation and cancer. Adv Cancer Res, 44, 139-266.
5. Mignatti P, Robbins E and Rifkin DB, 1986, Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-98.
6. Terranove VP, Maslow D and Markus G, 1989, Directed migration of murine and human tumor cells to collagenases and other proteases. Cancer Res, 49, 4835-1.
7. Wong RS and Passaro E, 1989, Growth factors, oncogenesis and the autocrine hypothesis. Surg Gynecol Obstet, 160, 468-73.
8. Ng R, Kellen JA and Wong CHW, 1983, Plasminogen activators as markers of tumor colonization potential. Inv Met, 3, 243-8.
9. Ossowski L, Clunie G, Masucci MT and Blasi F, 1991, In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol, 107, 1107-12.
10. Ossowski L, 1988, In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of surface-bound urokinase. J Cell Biol, 107, 2437-45.
11. Rabbani SA, Harakadis P, Davidson DJ, et al. 1995, Prevention of prostate cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA). Int J Cancer, 63, 840-5.
12. Ossowski R and Reich E, 1983, Antibodies to plasminogen activator inhibit human tumor metastasis. Cell, 35, 611-19.
13. Crowlev CW, Cohen RL, Lucas BK, et al. 1993, Prevention of metastasis by inhibition of the urokinase receptor. Cell Biol, 90, 5021-5.
14. Kellen JA, Mirakian A and Kolin A, 1988, Antimetastatic effect of amiloride in an animal tumor model. Anticancer Res, 8, 1373-6.
15. Evans DM and Lin PL, 1995, Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. The Am Surg, 8, 692-7.
16. Baker MS, Bleakley P, Woodrow G and Doe WF, 1990, Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degeneration. Cancer Res, 50, 4676-84.
17. Koo JY, Parekh D, Townsend CM, et al. 1992, Amiloride inhibits the growth of human colon cancer cells in vitro. Surg Oncol, 1, 385-9.
18. Vassalli JD and Belin D, 1987, Amiloride selectively inhibits the urokinase-type plasminogen activator. Febs Lett, 214, 187-91.
19. Alliegro MC, Alliegro MA, Cragoe EJ and Glaser BM, 1993, Amiloride inhibition of angiogenesis in vitro. J Exp Zool, 267, 245-52.
20. Averv RL, Connor TB and Farazdaghi M, 1990, Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophth, 108, 1474-6.
21. Bonus DJ, 1982, Amiloride: A molecular probe of sodium transport in tissues and cells. Am J Physiol, 242, 131-45.
22. Ulrich-Baker MG, Wang P, Fitzpatrick L and Johnson LR, 1988, Amiloride inhibits rat mucosal ODC activity and DNA synthesis. Am J Physiol, 254, 405-15.
23. Riley JH and Cornelius LM, 1989, Electrolytes, blood gasses and acid base balance. In: Loeb WF and Quimby FW, eds. The Clinical Chemistry of Laboratory Animals. Oxford: Pergamon Press, pp. 345-406.